Barrett & Company’s Sylvamo SLVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83K Buy
49
+1
+2% +$41 ﹤0.01% 630
2026
Q1
$2.03K Hold
48
﹤0.01% 579
2025
Q4
$2.29K Buy
48
+1
+2% +$46 ﹤0.01% 579
2025
Q3
$2.08K Hold
47
﹤0.01% 583
2025
Q2
$2.33K Buy
47
+1
+2% +$56 ﹤0.01% 576
2025
Q1
$3.1K Hold
46
﹤0.01% 529
2024
Q4
$3.63K Hold
46
﹤0.01% 524
2024
Q3
$3.93K Buy
46
+1
+2% +$75 ﹤0.01% 503
2024
Q2
$3.12K Hold
45
﹤0.01% 520
2024
Q1
$2.79K Hold
45
﹤0.01% 529
2023
Q4
$2.21K Hold
45
﹤0.01% 528
2023
Q3
$1.98K Hold
45
﹤0.01% 546
2023
Q2
$1.82K Hold
45
﹤0.01% 538
2023
Q1
$2.08K Hold
45
﹤0.01% 512
2022
Q4
$2.19K Hold
45
﹤0.01% 511
2022
Q3
$2.19K Buy
+45
New +$1.71K ﹤0.01% 511

Other funds holding SLVM

Barrett & Company's SLVM Position: Q2 2026 in Review

Barrett & Company increased its Sylvamo (SLVM) stake by 2.1% in Q2 2026, buying an estimated $41 and bringing the position to 49 shares worth $1.83K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

Barrett & Company first reported a position in SLVM in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.93K in Q3 2024. 332 funds tracked by Wall St. Rank hold SLVM as of Q2 2026.

  • Barrett & Company held 49 shares of Sylvamo worth $1.83K as of Q2 2026.
  • Barrett & Company bought 1 Sylvamo share in Q2 2026, an estimated $41.
  • Sylvamo made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #630 holding.
  • Barrett & Company first reported a position in Sylvamo in Q3 2022 and has held it in 16 quarters since.
  • Barrett & Company's Sylvamo position peaked at $3.93K in Q3 2024.
  • 332 funds tracked by Wall St. Rank held Sylvamo as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.